Urgent care center operator Bloom Care has agreed to pay $3 million to settle allegations that it submitted false claims to federal healthcare programs for medically unnecessary testing and inflated the extent of services performed.
What happened?
- Bloom Care operated urgent care centers in Idaho and New Mexico throughout the COVID-19 pandemic, according to a July 15 Justice Department news release.
- The department alleged that the company knowingly used the pandemic as an excuse to bill medically unnecessary streptococcus and influenza tests for asymptomatic patients.
- The company also allegedly submitted claims for high-level evaluation and management services for COVID-19 patients that it knew should have been billed at a lower level of service. To justify the high reimbursement claims, Bloom allegedly exaggerated the time spent with COVID-19 patients or the complexity of the evaluation required to care for them.
- The claims resolved in the settlement are allegations only, and there has been no admission or determination of liability.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
